Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancer

被引:0
|
作者
Peter A. Fasching
Paul Gass
Lothar Häberle
Bernhard Volz
Alexander Hein
Carolin C. Hack
Michael P. Lux
Sebastian M. Jud
Arndt Hartmann
Matthias W. Beckmann
Dennis J. Slamon
Ramona Erber
机构
[1] Friedrich Alexander University of Erlangen-Nuremberg,Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen
[2] University of California at Los Angeles,EMN, Erlangen University Hospital
[3] Friedrich Alexander University of Erlangen-Nuremberg,Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine
[4] Friedrich Alexander University of Erlangen-Nuremberg,Biostatistics Unit, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen
来源
Breast Cancer Research and Treatment | 2019年 / 175卷
关键词
Breast cancer; Ki-67; Proliferation; Molecular marker; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:617 / 625
页数:8
相关论文
共 50 条
  • [31] The 70-Gene Signature as Prognostic Factor for Elderly Women with Hormone Receptor-Positive, HER2-Negative Breast Cancer
    Hartmann, Steffi
    Gerber, Bernd
    Elling, Dirk
    Heintze, Kristin
    Reimer, Toralf
    BREAST CARE, 2012, 7 (01) : 19 - 24
  • [32] Challenges in the treatment of hormone receptor-positive, HER2-negative metastatic breast cancer with brain metastases
    Minetta C. Liu
    Javier Cortés
    Joyce O’Shaughnessy
    Cancer and Metastasis Reviews, 2016, 35 : 323 - 332
  • [33] Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancers
    Fujimoto, Yukie
    Watanabe, Takahiro
    Hida, Akira I.
    Higuchi, Tomoko
    Miyagawa, Yoshimasa
    Ozawa, Hiromi
    Bun, Ayako
    Fukui, Reiko
    Sata, Atsushi
    Imamura, Michiko
    Hirota, Seiichi
    Miyoshi, Yasuo
    BREAST CANCER, 2019, 26 (06) : 738 - 747
  • [34] Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancers
    Yukie Fujimoto
    Takahiro Watanabe
    Akira I. Hida
    Tomoko Higuchi
    Yoshimasa Miyagawa
    Hiromi Ozawa
    Ayako Bun
    Reiko Fukui
    Atsushi Sata
    Michiko Imamura
    Seiichi Hirota
    Yasuo Miyoshi
    Breast Cancer, 2019, 26 : 738 - 747
  • [35] The Clinical Utility of ESR1 Mutations in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
    Grinshpun, Albert
    Sandusky, Zachary M.
    Jeselsohn, Rinath
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (01) : 169 - 181
  • [36] Challenges in the treatment of hormone receptor-positive, HER2-negative metastatic breast cancer with brain metastases
    Liu, Minetta C.
    Cortes, Javier
    O'Shaughnessy, Joyce
    CANCER AND METASTASIS REVIEWS, 2016, 35 (02) : 323 - 332
  • [37] Association among T2 signal intensity, necrosis, ADC and Ki-67 in estrogen receptor-positive and HER2-negative invasive ductal carcinoma
    Kim, Soo-Yeon
    Kim, Eun-Kyung
    Moon, Hee Jung
    Yoon, Jung Hyun
    Koo, Ja Seung
    Kim, Sungheon Gene
    Kim, Min Jung
    MAGNETIC RESONANCE IMAGING, 2018, 54 : 176 - 182
  • [38] Importance of Ki-67 in human epidermal growth factor receptor 2 positive breast cancer
    Erdogan, Bulent
    Turkmen, Esma
    Yalta, Tulin Deniz
    Usta, Ufuk
    Kodaz, Hilmi
    Hacibekiroglu, Ilhan
    Tanriverdi, Ozgur
    Uzunoglu, Sernaz
    Cicin, Irfan
    JOURNAL OF BUON, 2015, 20 (03): : 730 - 736
  • [39] A Representative Clinical Course of Progression, with Molecular Insights, of Hormone Receptor-Positive, HER2-Negative Bone Metastatic Breast Cancer
    Magno, Elizabeth
    Bussard, Karen M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (06)
  • [40] Prognostic stratification of oestrogen receptor-positive HER2-negative lymph node-negative class of breast cancer
    Rakha, Emad A.
    Agarwal, Devika
    Green, Andrew R.
    Ashankyty, Ibraheem
    Ellis, Ian O.
    Ball, Graham
    Alaskandarany, Mohammed A.
    HISTOPATHOLOGY, 2017, 70 (04) : 622 - 631